Both are true.
GMV completed clinical trial in early 2019, unfortunately was randomisely seleted for re-trial on 19/05/2019.
you can find the annocement on mpa.gd.gov.cn
- Forums
- ASX - By Stock
- GMV
- GMVD - NASDAQ IPO
GMVD - NASDAQ IPO, page-29
-
- There are more pages in this discussion • 1,903 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online